HomeNewsBusinessStartupSaaS startups rework plans to thrive in a post-coronavirus world

SaaS startups rework plans to thrive in a post-coronavirus world

These firms are looking at small businesses and also broadening client-base as consumer behaviour changes

May 27, 2020 / 12:22 IST
Story continues below Advertisement

They are the quiet corner of the information technology world. Away from the talk-of-the-town fundraisings, and also layoffs, of the consumer internet startups, software-as-a-service (SaaS) firms have been hard at work, sometimes also serving their headline-hogging peers.

As the coronavirus pandemic decimates business and brings companies back to the drawing board, SaaS startups, too, are switching lanes to tide over the unprecedented disruption.

Pivoting models, the industry speak for a shift to a new strategy, finding new customers and changing price points are some of the measures they have taken.

Story continues below Advertisement

For instance, Seekify, a customer-experience platform aimed at large consumer-facing businesses, is changing plans.

Barely a year old, Seekify works with mid-market firms that typically have 100-999 employees or enterprises, which have a workforce of more than a thousand. It helps them automate customer management issues, performance feedback and maps skills.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show